A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants

Vaccines against SARS-CoV-2 have alleviated infection rates, hospitalization and deaths associated with COVID-19. In order to monitor humoral immunity, several serology tests have been developed, but the recent emergence of variants of concern has revealed the need for assays that predict the neutra...

Descripción completa

Detalles Bibliográficos
Autores principales: Egia-Mendikute, Leire, Bosch, Alexandre, Prieto-Fernández, Endika, Vila-Vecilla, Laura, Zanetti, Samanta Romina, Lee, So Young, Jiménez-Lasheras, Borja, García del Río, Ana, Antoñana-Vildosola, Asier, de Blas, Ander, Velasco-Beltrán, Paloma, Serrano-Maciá, Marina, Iruzubieta, Paula, Mehrpouyan, Majid, Goldberg, Edward M., Bornheimer, Scott J., Embade, Nieves, Martínez-Chantar, María L., López-Hoyos, Marcos, Mato, José M., Millet, Óscar, Palazón, Asís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730237/
https://www.ncbi.nlm.nih.gov/pubmed/36505411
http://dx.doi.org/10.3389/fimmu.2022.1014309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730237/
https://www.ncbi.nlm.nih.gov/pubmed/36505411
http://dx.doi.org/10.3389/fimmu.2022.1014309

Ejemplares similares